Prolactin awareness: An essential consideration for physical health in schizophrenia
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference55 articles.
1. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report;Anghelescu;J. Clin. Psychiatry,2004
2. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response;Breier;Am. J. Psychiatry,1999
3. A pilot study of a structured interview addressing sexual function in men with schizophrenia;Burke;Biol. Psychiatry,1994
4. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors;Burris;J. Pharmacol. Exp. Ther.,2002
5. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics;Bushe;J. Psychopharmacol.,2007
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Outcomes following hip fracture surgery in adults with schizophrenia in Ontario, Canada: A 10-year population-based retrospective cohort study;General Hospital Psychiatry;2024-07
2. The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study;BMC Oral Health;2023-10-24
3. Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphisms;Pharmacological Reports;2022-12-16
4. “Amisulpride associated hyperprolactinemia and gynecomastia in a young male patient: A rare case report and systematic literature review of drug-induced hyperprolactinemia”;Psychiatry Research Case Reports;2022-12
5. Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma;Frontiers in Psychiatry;2022-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3